DA-020
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DA-020, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia [Phase 1, Phase 2]